Total Payments
$598,925
2024 Payments
$71,121
Companies
14
Transactions
167
Medicare Patients
565
Medicare Billing
$46,247
Payment Breakdown by Category
Consulting$516,880 (86.3%)
Travel$44,855 (7.5%)
Research$20,700 (3.5%)
Other$14,014 (2.3%)
Food & Beverage$2,476 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $516,880 | 84 | 86.3% |
| Travel and Lodging | $44,855 | 30 | 7.5% |
| Unspecified | $20,700 | 1 | 3.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,014 | 5 | 2.3% |
| Food and Beverage | $2,476 | 47 | 0.4% |
Payments by Type
General
$578,225
166 transactions
Research
$20,700
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $428,433 | 45 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $66,828 | 50 | $0 (2024) |
| Merck Sharp & Dohme LLC | $44,771 | 19 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $18,986 | 11 | $0 (2024) |
| EISAI INC. | $16,419 | 19 | $0 (2022) |
| Vertex Pharmaceuticals Incorporated | $11,315 | 5 | $0 (2022) |
| Millennium Pharmaceuticals, Inc. | $3,932 | 4 | $0 (2017) |
| Alkermes, Inc. | $3,571 | 4 | $0 (2019) |
| Avadel CNS Pharmaceuticals, LLC | $2,250 | 5 | $0 (2024) |
| Orion Corporation | $1,375 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71,121 | 19 | Takeda Pharmaceuticals U.S.A., Inc. ($65,400) |
| 2023 | $112,069 | 23 | Takeda Pharmaceuticals U.S.A., Inc. ($94,787) |
| 2022 | $114,131 | 24 | Takeda Pharmaceuticals U.S.A., Inc. ($100,262) |
| 2021 | $110,604 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($87,831) |
| 2020 | $56,620 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($37,950) |
| 2019 | $64,999 | 32 | Takeda Pharmaceuticals U.S.A., Inc. ($37,364) |
| 2018 | $42,385 | 19 | Merck Sharp & Dohme Corporation ($18,388) |
| 2017 | $26,996 | 20 | Merck Sharp & Dohme Corporation ($13,759) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Consulting Fee | Cash or cash equivalent | $1,725.00 | General |
| Category: Narcoplepsy | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,895.00 | General |
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $6,175.00 | General |
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $13,548.60 | General |
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $9,575.72 | General |
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $663.53 | General |
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $65.21 | General |
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $55.43 | General |
| 08/20/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 07/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $16,740.00 | General |
| 07/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 06/05/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 06/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $145.91 | General |
| 06/02/2024 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $182.83 | General |
| Category: NEUROLOGY | ||||||
| 06/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $85.65 | General |
| 04/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Consulting Fee | Cash or cash equivalent | $1,563.00 | General |
| Category: Narcoplepsy | ||||||
| 04/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $15,450.00 | General |
| 04/03/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 01/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $26,462.45 | General |
| 11/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $30,445.00 | General |
| 11/03/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $22,345.00 | General |
| 09/25/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: NEUROLOGY | ||||||
| 09/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $46.58 | General |
| 09/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $13.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 111 | 122 | $41,214 | $9,074 |
| 2022 | 5 | 138 | 153 | $54,378 | $13,492 |
| 2021 | 8 | 176 | 186 | $64,321 | $14,765 |
| 2020 | 4 | 140 | 142 | $47,912 | $8,916 |
Total Patients
565
Total Services
603
Medicare Billing
$46,247
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 70 | 76 | $24,776 | $5,386 | 21.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $8,450 | $1,909 | 22.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 20 | $4,660 | $1,340 | 28.8% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 13 | 13 | $3,328 | $439.68 | 13.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $21,450 | $5,607 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 36 | 44 | $14,344 | $3,418 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 43 | 46 | $10,166 | $2,257 | 22.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 14 | $4,690 | $1,231 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 16 | $3,728 | $978.84 | 26.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $11,700 | $3,161 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 26 | 31 | $10,040 | $2,558 | 25.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $7,938 | $2,026 | 25.5% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 18 | 18 | $8,892 | $1,870 | 21.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 29 | 31 | $6,851 | $1,719 | 25.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 24 | 25 | $7,725 | $1,305 | 16.9% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 30 | 30 | $7,680 | $1,166 | 15.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 15 | $3,495 | $960.76 | 27.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 52 | 53 | $14,101 | $3,032 | 21.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 41 | 42 | $16,423 | $2,775 | 16.9% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2020 | 15 | 15 | $7,410 | $1,221 | 16.5% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2020 | 20 | 20 | $5,120 | $1,175 | 23.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 12 | 12 | $4,858 | $712.25 | 14.7% |
About Dr. Thomas Scammell, M.D
Dr. Thomas Scammell, M.D is a Neurology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194762724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Scammell, M.D has received a total of $598,925 in payments from pharmaceutical and medical device companies, with $71,121 received in 2024. These payments were reported across 167 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($516,880).
As a Medicare-enrolled provider, Scammell has provided services to 565 Medicare beneficiaries, totaling 603 services with total Medicare billing of $46,247. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine
- Location Boston, MA
- Active Since 06/01/2006
- Last Updated 10/15/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1194762724
Products in Payments
- XYREM (Drug) $25,467
- BELSOMRA (Drug) $22,865
- Wakix (Drug) $12,998
- Xyrem (Drug) $8,381
- XYWAV (Drug) $7,100
- SUNOSI (Drug) $6,000
- WAKIX (Drug) $3,288
- Dayvigo (Drug) $2,406
- LUMRYZ (Drug) $2,250
- Sunosi (Drug) $30.67
- QUVIVIQ (Drug) $14.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boston
Christopher Wright, Md, MD
Neurology — Payments: $2.0M
Neurology $2.0M
Dr. Alfred Sandrock, Md Phd, MD PHD
Neurology — Payments: $1.2M
Neurology $1.2M
Patrick Wen, Md, MD
Neurology — Payments: $583,963
Neurology $583,963
Dr. Michael Levy, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $519,354
Neurology $519,354
Roy Freeman, M.d, M.D
Neurology — Payments: $489,143
Neurology $489,143
Dr. Sheena Chew, Md, MD
Neurology — Payments: $328,987
Neurology $328,987